Influx Healthtech logo

Influx Healthtech financials and balance sheet

NSE: INFLUXPharmaceuticals & Biotechnology

Last close ₹257.00down ₹1.10 (0.43%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹258.10.

52-week range of traded prices to 23 Oct 2026
₹168.50Low, 27 Oct 2025₹315.00High, 6 Jul 2026
Market cap
₹595 Cr
P/E
28.9
P/B
5.9
Dividend yield
Nonein the last 12 months
ROE
20.4%
Debt to equity
0.00
Volume, NSE
30,00080.0% delivered

1 year at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Influx Healthtech annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue147
  2. Materials and goods−87
  3. Employee costs−12
  4. Other expenses−19
  5. Operating profit30
  6. Depreciation−3.8
  7. Other income+1.3
  8. Finance costs−0.2
  9. Profit before tax27
  10. Tax−6.7
  11. Net profit21

What the company owns

  • Plant, investments and other assets₹47 Cr
  • Receivables₹34 Cr
  • Cash and bank₹25 Cr
  • Inventory₹16 Cr
  • Current investments₹2 Cr

What pays for it: net worth and liabilities

  • Net worth₹101 Cr
  • Owed to suppliers₹19 Cr
  • Other liabilities₹4 Cr

Profit and loss

Consolidated, ₹ crore, years to March.Influx Healthtech half-yearly results

₹ croreMar 2026Filed 20 May
Revenue from operations147
117
Materials and goods bought87
Employee costs12
Other expenses19
Operating profit before depreciation30
Operating margin20.3%
Materials, % of revenue59.0%
Employee costs, % of revenue8.0%
Other expenses, % of revenue12.6%
Depreciation and amortisation4
Operating profit after depreciation26
Other income1
Finance costs0
Profit before tax27
7
Net profit21
Net margin14.0%

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2026Filed 20 May
101
Share capital23
Reserves78
Borrowings0
23
Liabilities due after a year0
Total assets124
42
81
Net debt−27
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2026Filed 20 May
3.9
12.2
−18.1
Receivables−1.8
Inventories−2.7
Payables−10.3
Other working capital−3.3
Tax paid−8.3
Capital spending24.6
Free cash flow−20.7
−25.2
44.5
Dividends paid0.0
Shares issued44.7
Net change in cash23.3
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Consolidated, ₹ per share, years to March.

₹ per shareMar 2026Filed 20 May
Earnings per share₹9.35
Diluted earnings per share₹9.35
Book value per share₹43.52
Shareholder yield−9.6%
Market cap at the year end (₹ crore)468

Ratios

Consolidated, years to March.Influx Healthtech PE ratio and valuation

RatioMar 2026Filed 20 May
Return on equity20.4%
Return on capital employed25.9%
Cash conversion18.9%
Interest cover141.6
Debt to equity0.00
Receivable days84
Inventory days67
Payable days81
Cash conversion cycle, days71
Working capital days78
Asset turnover1.19
Assets per rupee of net worth1.23
Sales per rupee of plant5.33
Capital spending to depreciation6.50

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
16.6%
Cash from operations against operating profit
13.0%

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations3.9
Cash from investing−25.2
Cash from financing44.5
Capital spending24.6
Dividends paid0.0
Shares issued for cash44.7
Borrowings repaid0.0

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2026
Effective tax ratePublished threshold 17.16 per cent24.57
Tax charged less tax paid, % of profitOur threshold 10 percentage points−6.09
A threshold marked as ours has no published figure; it is the line we read the check against.